New appointment at BioMedPartners
This article was originally published in Scrip
The Swiss healthcare venture capital firm, BioMedPartners, has recruited Dr Andreas Schulze as a partner, and promoted Patrick Burgermeister to principal. Dr Schulze was previously CEO of the biotech company, Neurotune, and before that headed the biotech team at the German venture capital firm, DEWB. Mr Burgermeister joined BioMedPartners in 2006 from Novartis, where he was a senior portfolio manager.